Nan; Fajun

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nan; Fajun.The latest application filed is for "pentacyclic triterpene compound and preparation method therefor, and pharmaceutical composition and use thereof".

Company Profile

9.32.29

Nan; Fajun - Shanghai CN
NAN; Fajun - Pudong Shanghai
Nan; Fajun - Washington DC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pentacyclic triterpene compound and preparation method therefor, and pharmaceutical composition and use thereof Grant 11,192,916 - Nan , et al. December 7, 2	2021-12-07
GPR84 receptor antagonist and use thereof Grant 11,098,071 - Nan , et al. August 24, 2	2021-08-24
Aryl-2,2'-tandem bisthiazole compound and preparation method and use thereof Grant 10,766,889 - Nan , et al. Sep	2020-09-08
Pentacyclic Triterpene Compound And Preparation Method Therefor, And Pharmaceutical Composition And Use Thereof App 20200231623 - NAN; Fajun ; et al.	2020-07-23
Gpr84 Receptor Antagonist And Use Thereof App 20200010492 - NAN; Fajun ; et al.	2020-01-09
Fatty acid compound, preparation method therefor and use therefor Grant 10,414,713 - Nan , et al. Sept	2019-09-17
Aryl-2,2'-tandem Bisthiazole Compound And Preparation Method And Use Thereof App 20190211005 - NAN; Fajun ; et al.	2019-07-11
KCNQ potassium channel agonist, and preparation method therefor and use thereof Grant 10,316,008 - Nan , et al.	2019-06-11
Tricyclic analogues, preparation method and uses thereof Grant 10,278,962 - Nan , et al.	2019-05-07
Fatty Acid Compound, Preparation Method Therefor And Use Therefor App 20190039989 - NAN; Fajun ; et al.	2019-02-07
One class of pyrazolone compounds and use thereof Grant 10,196,389 - Nan , et al. Fe	2019-02-05
KCNQ potassium channel agonists, method of preparation and method of use thereof Grant 10,077,245 - Nan , et al. September 18, 2	2018-09-18
Compounds Having Agonistic Effect Against Gpr84, Preparation Method For Compounds And Use Of Compounds App 20180237399 - NAN; Fajun ; et al.	2018-08-23
Novel Kcnq Potassium Channel Agonist, And Preparation Method Therefor And Use Thereof App 20180134677 - Nan; Fajun ; et al.	2018-05-17
Tricyclic Analogues, Preparation Method And Uses Thereof App 20180064696 - NAN; Fajun ; et al.	2018-03-08
One Class Of Pyrazolone Compounds And Use Thereof App 20170247371 - NAN; Fajun ; et al.	2017-08-31
2,2'-tandem dithiazole compound, preparation method therefor, and use thereof Grant 9,643,941 - Nan , et al. May 9, 2	2017-05-09
Novel Kcnq Potassium Channel Agonists, Method Of Preparation And Method Of Use Thereof App 20170081301 - NAN; Fajun ; et al.	2017-03-23
2,2'-tandem Dithiazole Compound, Preparation Method Therefor, And Use Thereof App 20170044119 - NAN; Fajun ; et al.	2017-02-16
Compound as KCNQ potassium channel agonist, preparation method therefor and use thereof Grant 9,353,048 - Nan , et al. May 31, 2	2016-05-31
Thiazole compounds, methods for preparation and use thereof Grant 9,216,962 - Nan , et al. December 22, 2	2015-12-22
Novel Compound As Kcnq Potassium Channel Agonist, Preparation Method Therefor And Use Thereof App 20140336252 - Nan; Fajun ; et al.	2014-11-13
Novel Alkene Oxindole Derivatives App 20140288127 - Chen; Li ; et al.	2014-09-25
Alkene oxindole derivatives Grant 8,778,973 - Chen , et al. July 15, 2	2014-07-15
Thiazole Compounds, Methods For Preparation And Use Thereof App 20140148600 - Nan; Fajun ; et al.	2014-05-29
Heterocyclic non-nucleoside compounds, their preparation, pharmaceutical composition and their use as antiviral agents Grant 8,653,115 - Nan , et al. February 18, 2	2014-02-18
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase Grant 8,609,721 - Kozikowski , et al. December 17, 2	2013-12-17
Alpha-amino-N-substituted amides, pharmaceutical composition containing them and uses thereof Grant 8,470,763 - Nan , et al. June 25, 2	2013-06-25
Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof Grant 8,455,510 - Nan , et al. June 4, 2	2013-06-04
Novel Alkene Oxindole Derivatives App 20130131114 - Chen; Li ; et al.	2013-05-23
2',2-bisthiazole non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof Grant 8,426,606 - Nan , et al. April 23, 2	2013-04-23
2',2-dithiazol Non-nucleoside Compounds, Preparation Methods, Pharmaceutical Compositions And Uses As Hepatitis Virus Inhibitors Thereof App 20130059895 - Nan; Fajun ; et al.	2013-03-07
Pharmaceutical Use of 2',2-Bis-Thiazole Non-Nucleoside Compounds as Hepatitis C Virus Inhibitor App 20120264793 - Nan; Fajun ; et al.	2012-10-18
Method for preparing 4-(6-amino-purin-9-YL)-2(S)-hydroxy-butyric acid methyl ester Grant 8,247,549 - Nan , et al. August 21, 2	2012-08-21
Protein tyrosine phosphatase 1B inhibitor, preparation methods and uses thereof Grant 8,183,383 - Nan , et al. May 22, 2	2012-05-22
Substituted cyclic compound, its preparation process and its medical use Grant 8,039,492 - Wang , et al. October 18, 2	2011-10-18
Method for Preparing 4-[9-(6-Aminopurine)]-2-(S)-Hydroxyl-Butyric Acid Methyl Ester App 20110201810 - Nan; Fajun ; et al.	2011-08-18
Rapamycin Carbonic Ester Analogues, Pharmaceutical Compositions, Preparations and Uses Thereof App 20110166172 - Nan; Fajun ; et al.	2011-07-07
Alpha-Amino-N-Substituted Amides, Pharmaceutical Composition Containing Them and Uses Thereof App 20110021624 - Nan; Fajun ; et al.	2011-01-27
Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same Grant 7,838,682 - Nan , et al. November 23, 2	2010-11-23
Protein Tyrosine Phosphatase 1B Inhibitor, Preparation Methods and Uses Thereof App 20100197927 - Nan; Fajun ; et al.	2010-08-05
Subsituted Cyclic Compound, Its Preparation Process And Its Medical Use App 20100168183 - Wang; Mingwei ; et al.	2010-07-01
Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds Grant 7,741,348 - Nan , et al. June 22, 2	2010-06-22
Isoquinoline-1,3,4-trione compounds, the synthetic method and the use thereof Grant 7,683,073 - Nan , et al. March 23, 2	2010-03-23
Heterocyclic Non-Nucleoside Compounds, Their Preparation, Pharmaceutical Composition And Their Use As Antiviral Agents App 20100056569 - Nan; Fajun ; et al.	2010-03-04
Bisheterocycle Tandem Compounds Useful as Antiviral Agents, the Uses Thereof and the Compositions Comprising Such Compounds App 20080306121 - Nan; Fajun ; et al.	2008-12-11
Ligands For Metabotropic Glutamate Receptors And Inhibitors Of Naaladase App 20080176821 - Kozikowski; Alan P. ; et al.	2008-07-24
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase Grant 7,381,745 - Kozikowski , et al. June 3, 2	2008-06-03
Glucagon-like peptide-1 receptor agonists, the preparation and the use of the same App 20070043093 - Nan; Fajun ; et al.	2007-02-22
Isoquinoline-1,3,4-trione compounds, the synthetic method and the use thereof App 20060135557 - Nan; Fajun ; et al.	2006-06-22
Methionine aminopeptidase inhibitor App 20050113420 - Nan, Fajun ; et al.	2005-05-26
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase App 20040002478 - Kozikowski, Alan P. ; et al.	2004-01-01
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase Grant 6,528,499 - Kozikowski , et al. March 4, 2	2003-03-04
Ligands for metabotropic glutamate receptors and inhibitors of NAALAdase Grant 6,479,470 - Kozikowski , et al. November 12, 2	2002-11-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.